Approach To Thrombosis Flashcards

(35 cards)

1
Q

What are the social correlates related to thrombotic disorders?

A

Traffic, road users, organization, regulatory mechanisms

These factors can influence the prevalence and management of thrombotic disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the main goal of haemostasis?

A

To stop bleeding and to do so only at the site of injury

This involves a balance between pro-coagulant and anticoagulant mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does Virchow’s triad consist of?

A

Three components: stasis, hypercoagulability, endothelial injury

These factors contribute to the risk of thrombosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two main processes of haemostasis?

A
  • Primary haemostasis
  • Secondary haemostasis

Primary involves vasoconstriction and platelet plug formation; secondary involves coagulation factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of platelets in primary haemostasis?

A

Formation of a platelet plug

This is the first physiological response to blood vessel injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the purpose of secondary haemostasis?

A

To stabilize and reinforce the weak platelet plug and convert fibrinogen to fibrin

This prevents further blood loss from the injury site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name two key components involved in the coagulation pathways.

A
  • Tissue factor (TF)
  • Calcium

These components are essential for the activation of coagulation factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the main steps in the cell-based model of haemostasis?

A
  • Initiation
  • Amplification
  • Propagation

These steps describe how coagulation factors are activated to form fibrin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are promoters of fibrinolysis?

A
  • Plasmin
  • Tissue plasminogen activator (tPA)

These substances help dissolve clots and restore blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are inhibitors of fibrinolysis?

A
  • Antiplasmin
  • Plasminogen activator inhibitor-1 (PAI-1)

These substances prevent excessive clot breakdown.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What factors can contribute to acquired risk factors for thrombosis?

A
  • Age
  • Pregnancy
  • Trauma
  • Surgery
  • Immobility
  • Malignancy

These factors can increase the risk of thrombotic events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is thrombotic thrombocytopenic purpura (TTP)?

A

A condition characterized by renal failure, hemolytic anemia, and thrombocytopenia

Treatment includes fresh frozen plasma and plasma exchange.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a common inherited thrombophilia condition?

A

Factor V Leiden

This condition increases the risk of thrombosis and is prevalent in Caucasian populations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fill in the blank: The process of _______ stabilizes and reinforces the clot formed during primary haemostasis.

A

Secondary haemostasis

This involves the conversion of fibrinogen to fibrin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: Antithrombin deficiency is an autosomal dominant condition.

A

True

This condition significantly increases the risk of thrombosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the two physiological responses involved in primary haemostasis?

A
  • Local vasoconstriction
  • Platelet plug formation

These responses occur immediately after vascular injury.

17
Q

What is the function of the vascular endothelium in haemostasis?

A
  • Anticoagulant properties
  • Procoagulant properties

It regulates the balance between bleeding and clotting.

18
Q

What does a thrombophilia screen test for?

A

Deficiencies or abnormalities in coagulation factors

This helps identify the underlying causes of thrombotic events.

19
Q

What are the three main components of Virchow’s triad?

A
  • Stasis
  • Endothelial injury
  • Hypercoagulability

These factors contribute to thrombosis risk.

20
Q

What is Factor V Leiden?

A

Commonest genetic risk factor for thrombosis, present in 5% of Caucasian population, rare in black and Asian populations. Causes activated protein C resistance, increasing risk by 7%.

Factor V Leiden is a mutation that affects the clotting process, leading to increased risk of venous thromboembolism.

21
Q

What is the Prothrombin 20210 mutation?

A

G20210A mutation on chromosome 11, increases risk of thrombosis by 3%.

This mutation leads to elevated levels of prothrombin, a clotting factor, which can contribute to venous clots.

22
Q

What is the prevalence of Protein C deficiency?

A

Prevalence is 0.2-0.3%, inherited in an autosomal dominant manner, located on chromosome 2, and increases thrombosis risk by 10-15%.

Protein C plays a crucial role in regulating blood coagulation.

23
Q

What is Protein S deficiency?

A

An autosomal dominant condition located on chromosome 3, liver and vitamin K dependent, increasing thrombosis risk by 2%.

Protein S is a cofactor for Protein C, and its deficiency can lead to increased clot formation.

24
Q

What are common investigations for thrombosis diagnosis?

A

Doppler ultrasound scan, venogram.

These imaging techniques help visualize clots in veins, particularly in the legs.

25
What is included in a thrombophilia screen?
Lupus anticoagulant, CD55/59, Protein C/S/Antithrombin, Factor V Leiden, Prothrombin 20210. ## Footnote This screen helps identify inherited or acquired conditions that predispose to thromboembolism.
26
What is the purpose of the Wells Criteria for DVT?
To assess the clinical probability of DVT based on specific features and risk factors. ## Footnote The Wells Criteria assigns points for various clinical features to categorize patients into high, moderate, or low probability of DVT.
27
What clinical feature scores 1 point in the Wells Criteria for DVT?
Active cancer, paralysis or paresis, recent immobilization of lower extremities, localized tenderness along deep veins, entire leg swollen, calf swelling by >3 cm, pitting edema, collateral superficial veins. ## Footnote Each feature contributes to the overall score used to determine the likelihood of DVT.
28
What is the indication for anticoagulation in thrombosis treatment?
To prevent progression of thrombosis and reduce the risk of embolism. ## Footnote Anticoagulation therapy is crucial in managing venous thromboembolism, including DVT and PE.
29
What are the side effects of Warfarin?
Hemorrhagic complications (intracerebral, GIT, hematuria, epistaxis), skin necrosis, purple toe, allergic reactions, hepatic dysfunction, teratogenic effects. ## Footnote Warfarin requires careful monitoring due to its risk of bleeding and other side effects.
30
What is the half-life of S-warfarin?
45 hours. ## Footnote S-warfarin is more potent than R-warfarin and is primarily responsible for anticoagulant activity.
31
What is the primary mechanism of action for Heparin?
Inhibits thrombin (FIIa) and factor Xa (FXa) in the coagulation cascade. ## Footnote Heparin works by enhancing the activity of antithrombin, leading to decreased thrombin formation.
32
What is the difference between high molecular weight heparin (HMWH) and low molecular weight heparin (LMWH)?
HMWH has a variable bioavailability and requires monitoring with APTT; LMWH has predictable bioavailability and usually does not require monitoring. ## Footnote The choice between HMWH and LMWH depends on patient factors and treatment goals.
33
What are the risk factors for hemorrhagic complications in patients on Warfarin?
Old age, poor anticoagulant control, prolonged treatment duration, and specific sites of bleeding. ## Footnote Identifying these risk factors can help mitigate the risk of severe bleeding events.
34
What is the target INR for DVT treatment with Warfarin?
2-3. ## Footnote Maintaining the INR within this range is essential to balance the risk of thrombosis and bleeding.
35
What should be done if a patient's INR is above the therapeutic range?
Consider holding the dose, administering vitamin K, or fresh frozen plasma for rapid reversal. ## Footnote The strategy for reversal depends on the level of INR and the urgency of the situation.